專家論壇

5336例利奈唑胺用藥人群相關(guān)血小板減少的自動監(jiān)測與評價研究···········郭代紅，胡鵬洲，朱 曼，賈王平，王嘯宇（4）：197

臨床評價

GPⅢа PLA2、PEAR1、PTGS1基因多態(tài)性與阿司匹林臨床

抗血栓療效關(guān)聯(lián)性研究···········································石秀錦，胡志旭，彭文星，李 驍，徐曉宇，續(xù)茜橋，林 陽（1）：1

中國癲癇患者基因組學(xué)研究現(xiàn)狀的循證評價························楊 靜，楊春松，黃 亮，俞 丹（2）：67

基于決策樹模型對我國6種保肝藥物治療藥物性肝損傷的成本-效果分析······················田艷平，崔向麗，劉麗宏，張長平（3）：131

醒腦靜注射液治療膿毒癥患者的臨床療效及血流動力學(xué)、免疫功能的影響·································劉 妍，王景霞，王艷春（3）：136

熊去氧膽酸聯(lián)合恩替卡韋治療慢性重型肝炎伴膽汁淤積患者療效分析···································袁淑芳，阿依夏木古麗·沙得爾，王晴晴，劉志英，張躍新（4）：201

丙戊酸對癲癇患者血漿纖維蛋白原水平的影響及相關(guān)因素分析·································唐 靜，楊迦雯，齊曉漣（5）：259

PEG-rhG-CSF與rhG-CSF預(yù)防腫瘤化療相關(guān)發(fā)熱性中性粒細(xì)胞減少癥的臨床療效及安全性比較的Meta分析······················黃 麗，劉 珂，羅圣平，譚秋紅（5）：264

神經(jīng)外科圍手術(shù)期纖維蛋白原降低與丙戊酸鈉關(guān)聯(lián)性分析······················································彭文星，周 洋，石秀錦，徐曉宇，林 陽（6）：319

實驗研究

HPLC-HG-AFS法測定亞砷酸治療的急性早幼粒細(xì)胞白血病患者尿液中砷代謝產(chǎn)物··············王文靜，胡 爽，郭美華，高春璐，海 鑫（1）：5

兩種硫間苯二酚洗劑微生物限度檢查的方法建立及適用性研究·························田懷平，林志燕，李 超，胡燕鋒（1）：9

雞血藤醇提物及其活性成分兒茶素對輻射損傷小鼠脾臟JAK/STAT通路的影響···········································董憲喆，王琪珊，牛 可，譚 瀟，郭代紅，劉 屏（2）：72

HPLC法同時測定山豆根中4種生物堿及其含量···········································何超然，李 哲，李 任，王麗麗，沈 素，余俊先（2）：77

肺結(jié)核患者利福噴丁血藥濃度監(jiān)測研究························彭明麗，陳 明，溫筱煦，趙冠人（2）：81

定志小丸調(diào)控氧化還原系統(tǒng)干預(yù)5-羥色胺水平的研究···········································張?zhí)焖?，董憲喆，馮 霞，朱維煜，胡 園，劉 屏（3）：140

高效液相色譜法測定人血漿中左乙拉西坦的藥物濃度······················································蔡 樂，朱 英，張明華，陳靜靜，柴 棟（3）：145

HPLC法測定腎樂膠囊中阿魏酸含量·············································王歡歡，黃曉舞（4）：204

超高效液相色譜法測定替考拉寧血藥濃度·································王艷紅，任秋霞，趙慶國（4）：207

左旋奧拉西坦在腦缺血再灌注模型大鼠體內(nèi)的藥動學(xué)研究·································利 玲，胡 秀，利 莉（5）：270

結(jié)核患者血清尿酸與吡嗪酰胺血藥濃度關(guān)系研究······················陳 明，吳 珂，吳首蓉，趙冠人（5）：274

2D-LC/UV法測定苯妥英血藥濃度的臨床應(yīng)用·································院江麗，張寒娟，袁冬冬（5）：277

HPLC法測定患者血漿中利奈唑胺的藥物濃度···········································錢 釗，董增祥，郭美華，魯 靜，劉 亮，高春璐，茆俊東，海 鑫（6）：322

HPLC法測定撲麻滴鼻液中有效成分含量的方法學(xué)研究……………………………………任 韡，黃曉舞，劉 坤，蘇歡歡，范金釗，白 林，李 欣（6）：326

pPB修飾的肉蓯蓉苯乙醇總苷脂質(zhì)體的制備研究……………木尼熱·庫爾班，王 梅，由淑萍，劉 濤（6）：330

HPLC法測定復(fù)方金錢草丸中槲皮素的含量…………………………………………曹 紅，水彩紅，胡 丹，單婷婷，張貴英（6）：334

臨床藥師園地

1例AIH-PSC重疊綜合征合并潰瘍性結(jié)腸炎兒童患者的藥學(xué)監(jiān)護(hù)························朱 紅，陳 哲，王天珩，趙慶國（1）：13

從1例尿路感染患者探討兩性霉素B膀胱沖洗的臨床應(yīng)用··············································鄧彧斐，王東曉（1）：17

臨床藥師對1例甲氨蝶呤排泄延遲患兒的藥學(xué)監(jiān)護(hù)··············································陶興茹，陳海燕（1）：21

臨床藥師參與急性壞死性胰腺炎患者抗感染診治的實踐與分析···································李佳佳，王雲(yún)亮，羅宏麗（2）：85

1例PBC合并高膽固醇血癥及嚴(yán)重皮膚瘙癢患者的藥學(xué)監(jiān)護(hù)························朱 紅，陳喜翠，杜 薇，趙慶國（2）：89

1例風(fēng)濕性二尖瓣置換術(shù)后房顫患者的藥學(xué)監(jiān)護(hù)·································邵 丹，尹 航，閆曉慶（3）：148

1例多部位泛耐藥鮑曼不動桿菌重癥感染患者的用藥分析及藥學(xué)監(jiān)護(hù)·············································馬 靜，徐家兵（3）：151

1例化療致發(fā)熱性中性粒細(xì)胞減少癥兒童患者的藥學(xué)監(jiān)護(hù)···········································劉 旭，閆賦琴，薛 婧，劉 洋，呂娟麗，王 楠（3）：154

1例伊立替康所致嚴(yán)重腹瀉伴粒細(xì)胞缺乏患者的治療分析與藥學(xué)監(jiān)護(hù)·································蔣 婷，袁明勇，鄭玲利（4）：211

臨床藥師參與1例高血壓患者冠心病一級預(yù)防的體會······················楊 賢，王文曉，嚴(yán)思敏，葛衛(wèi)紅（4）：215

臨床藥師參與1例西酞普蘭致QT間期延長的實踐與分析···········唐文誠，羅 文，王繼生，陳 靜，劉真宏（5）：280

1例IgA腎病合并MSI-H結(jié)腸癌術(shù)后患者的藥學(xué)監(jiān)護(hù)·············································岳喜波，許 耀（5）：283

結(jié)腸濾泡性淋巴瘤伴拉米夫定耐藥乙型肝炎患者的治療分析與藥學(xué)監(jiān)護(hù)······················李元元，劉 玨，周 慶，鄧艾平（6）：337

1例老年急性冠狀動脈綜合征患者的藥學(xué)監(jiān)護(hù)············································羅利雄，張秀芳（6）：340

不良反應(yīng)監(jiān)測

喹諾酮類藥物誘發(fā)/加重重癥肌無力個案匯總分析···································謝 歡，陳 穎，韋 鳳（1）：24

軍隊醫(yī)院310例喹諾酮類藥物嚴(yán)重藥品不良反應(yīng)/事件報告分析································黃翠麗，郭代紅，朱 曼，蘇 暢，吳 旭，趙粟裕，馬 亮，趙鵬芝，趙 靚（1）：28

基層醫(yī)療機構(gòu)216例藥物性肝損傷不良反應(yīng)分析與對策························張林祥，沈 明，邱 剛，趙穎斐（1）：32

1946例腫瘤患者化療及相關(guān)藥品不良反應(yīng)臨床分析···································王睿晴，張艷華，劉 紅（1）：36

2013 - 2016年我院2621例藥品不良反應(yīng)報告分析························林 珍，蔣 娟，吳小楓，史 濤（1）：40

馬來酸桂哌齊特注射液相關(guān)藥品不良反應(yīng)的智能化實時監(jiān)測研究························胡鵬洲，郭代紅，賈王平，石庭永（2）：92

臨床藥師干預(yù)對我院藥品不良反應(yīng)監(jiān)測的影響···································彭 洋，黃 琪，楊志玲（2）：96

101例藥源性睡眠障礙文獻(xiàn)分析···········································張東肅，蔡 樂，蘇 曄，史 紅，楊 梅，康 怡，朱 瑩（3）：158

1561例PPIs相關(guān)ADR分析及其肝功能異常風(fēng)險信號挖掘···········································龐 寧，郭代紅，趙粟裕，寇 煒，賈王平，胡鵬洲，楊鴻溢（4）：219

4476例大株紅景天注射液的安全性評價······················張新茹，孫秀波，謝莉娜，付秀娟（5）：286

210例抗菌藥物不良反應(yīng)報告分析·············································楊 瓊，李 麗（5）：291

氟比洛芬酯相關(guān)肝損害的自動監(jiān)測與風(fēng)險因素研究···········································劉 浩，宋艷東，趙粟裕，柴 棟，馬 亮，郭代紅（6）：344

我市2015 - 2017年601例兒童藥品不良反應(yīng)報告分析························································黃 婷（6）：348

我院2017年兒科住院患兒用藥情況及不良反應(yīng)分析·································李 忻，崔海珍，關(guān)麗英（6）：352

藥物利用分析

我院藥品不良事件中超說明書用藥分析························李 冬，劉 陽，楊 靖，胡 輝（1）：46

我院2014 - 2016年輔助用藥臨床應(yīng)用分析···································朱良榮，楊慧慧，林珍珍（1）：50

2060例乙酰半胱氨酸注射液的用藥評價···································崔海珍，于 倩，王 華（2）：99

臨床藥師聯(lián)合多部門干預(yù)對曲克蘆丁腦蛋白水解物使用效果分析······················································陳集志，李 剛，徐小燕，楊 洋，吳 駿（2）：102

我院三種平喘藥物不合理用藥分析·································邵 丹，嚴(yán)明蘭，李 忻（2）：106

2014 - 2016年武漢地區(qū)31家醫(yī)院改善腦血管循環(huán)藥物用藥分析·································徐艷嬌，黃 銳，劉 東（2）：109

我院2017年1 - 6月輔助用藥使用合理性分析································李 冬，胡 輝，陳 梅，彭 燕，王麗萍，韓忠靈，周曉麗，王思涵（3）：162

8008例注射用丹參多酚酸鹽的用藥分析·································畢鐵琳，于 倩，謝 程（3）：165

我院內(nèi)科住院患者口服抗高血壓藥物使用情況分析···········································邵曉迪，尹 紅，徐艷萍，龔虹霖，白 艷，徐風(fēng)華（3）：169

13 175例門診老年患者多藥治療調(diào)查與分析······················王 茹，郭代紅，李淵源，施華宇（4）：223

我院2017年靜脈用抗腫瘤藥物配置和使用分析及干預(yù)效果評價··········································羅 秀 ，楊小葉，黃美虹，呂 聰，蘭艷纖，曾尚勇，林素梅（4）：227

我院2016 - 2017年341例使用萬古霉素患者的用藥分析······················王震寰，侯嘉娜，萬里燕，魏建英（4）：230

6455例單唾液酸四己糖神經(jīng)節(jié)苷脂鈉合理用藥評價·································崔海珍，于 倩，李 忻（4）：236

臨床藥師干預(yù)下萬古霉素用藥行為分析···········································陳 玥，朱 曼，王秀英，劉 磊，羅鳴宇，柴 棟（5）：295

心臟外科Ⅰ類切口預(yù)防用抗菌藥物路徑式專項管理效果研究································石秀錦，秦 英，方振威，鄭青敏，劉治軍，王海燕，魏娟娟，徐曉宇，林 陽（5）：298

人血白蛋白臨床使用的深入分析和探討···········································安勝男，任文靜，王慧冰，鞠 蕾，張婉璐，付桂英（6）：356

我院剖宮產(chǎn)圍手術(shù)期抗菌藥物應(yīng)用分析······················································王 琦，武 東，曾 萍，袁小龍，汪曉娟（6）：359

藥學(xué)服務(wù)

以促進(jìn)精準(zhǔn)用藥為目的全球基因臨床應(yīng)用轉(zhuǎn)化評價模式的研究············楊春松，陳 靜，俞 丹，張伶俐，許群芬（1）：55

法國藥品臨床療效和臨床療效改善評級管理及其借鑒啟示·································盧碧香，關(guān)軼茹，張 方（2）：113

我院藥品不良反應(yīng)快速上報信息化系統(tǒng)應(yīng)用效果研究分析·································李 忻，于 倩，郭義明（3）：173

阿米替林治療帶狀皰疹后遺神經(jīng)痛的文獻(xiàn)計量分析·································張 明，楊 洋，白 楠（3）：177

中國抽動障礙患者西藥治療隨機對照試驗證據(jù)現(xiàn)狀與趨勢分析···········································楊 靜，王平平，俞 丹，黃 亮，張伶俐，楊春松（3）：181

立體式處方質(zhì)控新模式的實踐與效果評價······························· 侯繼秋，肖金寶，翟麗杰，王冬雪，于 玲，李 馨，付秀娟，王艷軍（4）：239

1997 - 2017年依替米星研究的文獻(xiàn)計量分析······················謝法紅，張新健，李德東，柴 棟（5）：303

臨床藥師干預(yù)骨科大手術(shù)患者預(yù)防深靜脈血栓效果評價······················································ 王艷麗，丁 亮，焦 萍，傅若芃，朱 曼（5）：307

危重癥患者應(yīng)激性潰瘍的危險因素及用藥現(xiàn)狀分析······················潘 晨，李丹丹，溫愛萍，沈 素（6）：363

從對北京居民用藥安全知信行的探索性調(diào)查看公眾用藥誤區(qū)······················································范倩倩，李秋月，朱 珠，梅 丹，唐 彥（6）：368

藥學(xué)進(jìn)展

危重癥患者萬古霉素相關(guān)腎毒性研究進(jìn)展································· 潘 晨，沈 素，溫愛萍（4）：242

案例分析

1例罕見的奧美拉唑致精神異常、幻視的案例分析··············································董利森，王東曉（1）：58

華法林聯(lián)用中藥致皮下出血1例···································翟慧媛，吳定坤，蘇曉葉（1）：62

注射用單唾液酸四己糖神經(jīng)節(jié)苷脂鈉致格林-巴利綜合征1例···································尹 航，于 倩，邵 丹（1）：64

1例胰島素致相關(guān)急性痛性神經(jīng)病變的案例分析·································張倩影，湯智慧，肖彥革（2）：118

孟魯司特鈉致嚴(yán)重精神系統(tǒng)紊亂1例·································李 蒙，楊 晨，袁恒杰（2）：121

唑來膦酸致嚴(yán)重低血鈣、低血鉀1例并文獻(xiàn)復(fù)習(xí)·············································李久旭，湯智慧（2）：123

美羅培南致肢體麻木活動受限1例····················· 侯繼秋，李 馨，肖金寶，辛秀琴（2）：126

垂體后葉素致腹瀉、重度低血鈉1例···········································王 哲，任遠(yuǎn)勤，舒 鶴，張 莉，張 萍，霍 焜（2）：128

替羅非班致重度血小板減少1例·································李艷嬌，董 雷，宋燕青（3）：185

碘帕醇注射液致尿失禁及尿潴留1例······························張笑穎，葉銀梅，才琴格樂（3）：187

哌拉西林/他唑巴坦致貧血1例·············································章 曄，何冰冰（3）：190

非布司他致藥疹1例及文獻(xiàn)回顧·································袁 微，劉 威，李運景（3）：193

補骨脂顆粒與驅(qū)白巴布期片聯(lián)用致藥物性肝損傷1例·············································張利利，黃景慧（4）：246

奧曲肽致注射部位反應(yīng)2例并文獻(xiàn)復(fù)習(xí)···········································唐 彥，金楊紅，張 謙，梅 丹，付 勇，柴曉峰，朱惠娟（4）：250

呋塞米致血小板減少1例·································張海芳，劉 杰，楊建平（4）：254

尖吻腹蛇血凝酶致高熱、呼吸困難1例······················································程剛英，周 慶，劉 玨，王 奕，鄧艾平（4）：256

莫西沙星注射液致白細(xì)胞、中性粒細(xì)胞伴其百分比減少2例·············································馬 靜，葛明坤（5）：311

替格瑞洛致呼吸困難1例·············································白 穎，王家偉（5）：313

氯沙坦鉀片致肝病伴腎功能不全患者無尿1例·································王天珩，朱 紅，姜彩娥（5）：316

華法林致鼻出血1例·············································蘭艷纖，韋美丹（6）：372

1例HLA-B*1502攜帶者三叉神經(jīng)痛治療的案例分析·············································陸曉蕾，謝 菡（6）：375

替加環(huán)素致重度肝損傷1例···········································程剛英，程 彪，周 慶，劉 玨，王 奕，鄧艾平（6）：378

2例重度肝硬化患者伏立康唑血藥濃度監(jiān)測與不良反應(yīng)分析······················································任秋霞，朱 紅，王艷紅，杜 薇，趙慶國（6）：381

信 息

案例分析欄目介紹··········································（1）：20

《中國藥物應(yīng)用與監(jiān)測》雜志2018年征訂啟事 ·······（1）：45

《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道··································································（1）：54

《中國藥物應(yīng)用與監(jiān)測》稿約 ·····························（1）：Ⅰ

《中國藥物應(yīng)用與監(jiān)測》雜志2018年征訂啟事 ·······（2）：95

《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道··································································（2）：98

臨床藥師園地欄目介紹···································（2）：105

臨床評價欄目介紹·········································（2）：130

臨床評價欄目介紹·········································（3）：168

臨床藥師園地欄目介紹···································（3）：172

《中國藥物應(yīng)用與監(jiān)測》雜志關(guān)于投稿的聲明 ·······（3）：189

案例分析欄目介紹·········································（3）：196

臨床藥師園地欄目介紹···································（4）：218

《中國藥物應(yīng)用與監(jiān)測》雜志關(guān)于投稿的聲明·································································（4）：222

《中國藥物應(yīng)用與監(jiān)測》雜志2019年征訂啟事 ······（5）：290

臨床藥師園地欄目介紹···································（5）：302

《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·································································（5）：306

《中國藥物應(yīng)用與監(jiān)測》雜志關(guān)于投稿的聲明·································································（6）：329

《中國藥物應(yīng)用與監(jiān)測》開通優(yōu)秀論文發(fā)表綠色通道·································································（6）：336

臨床評價欄目介紹·········································（6）：351

臨床藥師園地欄目介紹···································（6）：374

《中國藥物應(yīng)用與監(jiān)測》雜志2019年征訂啟事 ······（6）：380

案例分析欄目介紹·········································（6）：383